These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8484254)

  • 1. A new action mechanism of intravenous immunoglobulin for idiopathic thrombocytopenic purpura.
    Honda J; Natori H; Oizumi K; Yokoyama M
    Vox Sang; 1993; 64(3):186-7. PubMed ID: 8484254
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose intravenous immune globulin and the response to splenectomy monitoring with platelet-associated IgG in patients with idiopathic thrombocytopenic purpura.
    Kondo H; Imamura T
    Eur J Haematol; 1998 Sep; 61(3):213-5. PubMed ID: 9753419
    [No Abstract]   [Full Text] [Related]  

  • 3. Another interaction of the FcR system with IVIG.
    Bussel JB
    Thromb Haemost; 2002 Dec; 88(6):890-1. PubMed ID: 12529734
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of IVIG action in immune thrombocytopenic purpura.
    Hansen RJ; Balthasar JP
    Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor.
    Hansen RJ; Balthasar JP
    Thromb Haemost; 2002 Dec; 88(6):898-9. PubMed ID: 12529736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy.
    Mitsuhashi K; Ishiyama M; Imai Y; Shiseki M; Mori N; Teramura M; Seshimo A; Motoji T
    Br J Haematol; 2012 Sep; 158(6):798-800. PubMed ID: 22758388
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune thrombocytopenic purpura.
    Cines DB; Blanchette VS
    N Engl J Med; 2002 Mar; 346(13):995-1008. PubMed ID: 11919310
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic relevance of large-platelet counts in patients with immune thrombocytopenic purpura.
    Michel M; Kreidel F; Chapman ES; Zelmanovic D; Bussel JB
    Haematologica; 2005 Dec; 90(12):1715-6. PubMed ID: 16330456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Splenectomy in adult patients with idiopathic thrombocytopenic purpura after intravenous immunoglobulin treatment].
    Nowak T; Kucharski W; Scharf R
    Acta Haematol Pol; 1994; 25(1):31-5. PubMed ID: 8209611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.
    Jin F; Balthasar JP
    Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous gamma globulin treatment for chronic idiopathic thrombocytopenic purpura in children.
    Warrier I; Lusher JM
    Am J Med; 1984 Mar; 76(3A):193-8. PubMed ID: 6424451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin or megadose methylprednisolone for the treatment of idiopathic thrombocytopenic purpura.
    Ozsoylu S
    Am J Pediatr Hematol Oncol; 1991; 13(3):364-5. PubMed ID: 1817495
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia.
    Hansen RJ; Balthasar JP
    J Pharm Sci; 2003 Jun; 92(6):1206-15. PubMed ID: 12761810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of anti-inflammatory activity of intravenous immunoglobulin via inhibitory Fcgamma receptors.
    Maródi L
    Pediatr Res; 2001 Nov; 50(5):551. PubMed ID: 11641444
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura.
    Fabris F; Cordiano I; Girolami A
    N Engl J Med; 1997 Oct; 337(15):1088-9. PubMed ID: 9324643
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of idiopathic thrombopenic purpura in adolescents by intravenous immunoglobulin].
    Rodríguez Cuartero A; González Martínez F
    An Med Interna; 1998 Dec; 15(12):675-6. PubMed ID: 9972611
    [No Abstract]   [Full Text] [Related]  

  • 17. Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura.
    Mitterer M; Pescosta N; Vogetseder W; Mair M; Coser P
    Ann Hematol; 1993 Sep; 67(3):151-2. PubMed ID: 8373906
    [No Abstract]   [Full Text] [Related]  

  • 18. Harmful and beneficial antibodies in immune thrombocytopenic purpura.
    Imbach PA
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):25-30. PubMed ID: 8033430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of children with immune thrombocytopenic purpura: are we closer to resolving the dilemma?
    Modak SI; Bussel JB
    J Pediatr; 1998 Sep; 133(3):313-4. PubMed ID: 9738705
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of idiopathic thrombocytopenic purpura using a dose of immunoglobulin based on lean body mass.
    Woolfrey S; Dewar MS
    Ann Pharmacother; 1993 Apr; 27(4):510. PubMed ID: 8477131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.